More on WGS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-85.7% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (11/3/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

GeneDx Holdings (NQ:WGS)
Delayed: 61.26 --0 (-0%)
Prev. Close $61.26  
Open$61.26 
52 Wk High$ 
52 Wk Low$ 
Day High$61.26 
Day Low$61.26 
P/E N/A  
EPS$ 
Volume91 

Friends, Peers and Foes (?): GRAL, VRRM, BMI, NAVN, ILMN (more...)

Oct 23, 2026 04:05 PM GeneDx to Report Third Quarter 2026 Financial Results on Monday, November 9, 2026
Oct 20, 2026 04:05 PM GeneDx plans early access program for long-read genome sequencing
Oct 20, 2026 04:05 PM GeneDx Expands Diagnostic Leadership with Long-Read Genome Sequencing, Advancing Rare Disease Diagnosis
Oct 20, 2026 08:30 AM GeneDx plans early access program for long-read genome sequencing
Oct 20, 2026 08:30 AM GeneDx Expands Diagnostic Leadership with Long-Read Genome Sequencing, Advancing Rare Disease Diagnosis
Oct 19, 2026 04:05 PM GeneDx Advances Clinical Adoption of Genomic Medicine with 27 Abstracts at ASHG 2026
Oct 7, 2026 08:30 AM GeneDx Presents New Evidence Advancing Genomic Newborn Screening at ICoNS 2026
Oct 2, 2026 08:30 AM GeneDx Introduces Easy Order at AAP 2026 to Simplify Genomic Testing in Everyday Pediatric Care
Oct 1, 2026 08:48 AM GeneDx (WGS) PT Raised to $83 at Guggenheim
Sep 18, 2026 04:43 PM Form 4 GeneDx Holdings Corp. For: Sep 16 Filed by: Stueland Katherine
View All Articles

Entities mentioned with WGS

View All Entities